SlideShare a Scribd company logo
DRUGS USED IN
CRITICAL CARE
EMERGENCY
DRUGS
Purpose of Emergency Drugs
Details of Emergency Drugs
Mechanism of Action
Indication and Dose of the Drug
Drug Interaction
Contraindications
Adverse Effects of the Drug
Introduction
INTRODUCTION
Emergency drugs are chemical compounds used in patients during
life threatening conditions so that the symptoms can be controlled
and the life of a patient can be saved
For a drug to be useful in emergency, it must have a short onset of
action and be administered in such a way as to facilitate rapid onset of
action
PURPOSE OF EMERGENCY DRUGS
.
To provide initial
treatment for broard
spectrum of illness and
injuries, most of which
may be life threatening.
To control the
symptoms of patient.
To save the life of the
patient.
To reach the site of
action as soon as
possible.
To normalize the vital
bodily functions
To diverge the
patient from the
possible risks.
LIST OF
DRUGS
• Atropine
• Sodium
• Nitroprusside
• Amiodarone
• Aminophylline
• Mannitol
• Magnesium Sulfate
• Epinephrine
• Hydrocortisone
• Heparin
• Diazepam
ATROPINE
Indications and dose of the drug
• SINUS BRADYCARDIA: 0.5-1mg(or 5- 10ml of 0.1mg/ml) repeated every 3-5
min when necessary in adults.
• BRONCHOSPASM: 0.025mg/kg in 2.5ml NS via nebulizer every 6-8hrs
• Organophosphate poisoning: 2mg iv/im every 3 min. according to clinical
response in adult.
• Cardiac arrest: 1mg every 3-5 minutes
ATROPINE
Mechanism of Action
• It competitively blocks the muscarinic receptors in peripheral tissues
(heart, intestines, bronchial muscles, iris, secretory glands) and relaxes
the smooth muscles.
• The main action of vagus nerve of the parasympathetic system on the
heart is to slow it down and atropine blocks that action and speeds up
the heart rate
ATROPINE
Drug Interactions
The effect of the drug increases with
• Quinidine (Antiarrhythmic)
• Amitriptyline (Antidepressants)
• Diphenhydramine (antihistamine)
• Meclizine (antihistamine)
ATROPINE
Contraindications
• Narrow Angle Glaucoma
• Pyloric Stenosis
• Prostatic Hypertrophy
• Thyrotoxicosis
• Cardiac Failure
• Tachycardia
ATROPINE
Adverse effects of drug
• Palpitation
• Dry mouth
• Blurred vision
• Urinary retention and constipation
• Tachycardia
• Dysphagia
• Arrhythmias
• Hallucinations
• Raise intraocular pressure)
Indications and Dose of the drug
Sodium Nitroprusside(Nitropress)
Sodium nitroprusside is indicated for the immediate reduction of blood pressure
of patients in hypertensive crises. Concomitant longer-acting antihypertensive
medication should be administered so that the duration of treatment with sodium
nitroprusside can be minimized.
Dosage: 0.5-10 mcg/kg/min IV infusion
Mechanism Of Action
Sodium Nitroprusside(Nitropress)
The principal pharmacological action of sodium nitroprusside is relaxation of
vascular smooth muscle and consequent dilatation of peripheral arteries and
veins by producing Nitric Oxide thus reducing preload and afterload
Drug Interactions
Sodium Nitroprusside(Nitropress)
AVAN
AFIL
Nifedi
pine
Verap
amil
Clevidi
pine
Amlod
ipine
Contraindications
Sodium Nitroprusside(Nitropress)
Hypersensitivit
y
Acute
congestive
heart failure
with reduced
peripheral
vascular
resistance
Congenital
(Leber's) optic
atrophy
Tobacco
amblyopia
Adverse Effects
Sodium Nitroprusside(Nitropress)
Excessive
hypotensio
n
Metabolic
Acidosis
Cyanide
Toxicity
Raised
intracranial
Pressure
Thyroid
Suppressio
n
Bowel
Obstructio
n
Thiocyanat
e
Poisoning
Amiodarone
Indication and dose of the drug
Frequently
recurring
ventricular
fibrillation and
hemodynamicall
y unstable
ventricular
tachycardia
300mg IV after
epinephrine
dose if no
response to
defibrillation in
VT/VF
Intravenous
amiodarone also
can be used to
treat patients
with life
threatening
VT/VF
Amiodarone
Indication and dose of the drug
150mg IV bolus
in 10minutes,may
repeat as
necessary in
hemodynamicall
y unstable VT
VT=VENTRICUL
AR
TACHYCARDIA
VF=
VENTRIFULAR
FIBRILLATION
Amiodarone
Mechanism of Action
Amiodarone is generally considered a class III antiarrhythmic,
which inhibits adrenergic stimulation; affects sodium,
potassium and calcium channels; markedly prolongs action
potential and repolarization and decreases AV conduction
and sinus node function
Amiodarone
Interactions
Cimetidine: inhibits CYP3A4 and can increase serum amiodarone levels
Warfarin
Dofelitide
Amitriptyline
Propanolol
Digoxi
Amiodarone
Contraindications
Hypersensitivity
Avoid during
breastfeeding
Severe sinus node
dysfunction
Cardiogenic Shock
2 nd or 3rd degree
AV block
Amiodarone
Adverse Effects
Hypotensi
on
AV BLOCK
Congestive
Heart
Failure
Bradycardi
a
Cardiogeni
c Shock
Impaired
Memory
Aminophylline
Indications and Dose of the Drug
Acute exacerbations of the symptoms of reversible
airflow obstruction associated with asthma and
other chronic lung diseases, e.g.,emphysema and
chronic bronchitis
Dose: 5 – 7mg/kg IV/PO for over 20minutes
Aminophylline
Mechanism Of Action
• smooth muscle relaxation (i.e., bronchodilation)
• suppression of the response of the airways to
stimuli (i.e., nonbronchodilator prophylactic effects).
Aminophylline
Interactions
Dipyridamole
Riociguat
Ciprofloxacin
Febuxostat
Cimetidine
Cigarrete smoking
Aminophylline
Contraindications
Hypersensitivity
Underlying uncontrolled seizure disorder
Active peptic ulcer disease
Aminophylline
Adverse Effect
Serum Concentration<
20mcg/ml
Skeletal
Muscle
Tremors
Diarrhea
,Nausea,
Vomiting
Exfoliativ
e
Dermatiti
s
Tachyca
dia,
Flutter
Diuresis
Aminophylline
Adverse Effect
Serum Concentration>30mcg/ml
Acute Myocardial
Infarction
Seizures(resistant
to anticonvulsants)
Mannitol
Mechanism Of Action
Mannitol is an osmotic diuretic. It induces diuresis by elevating
the osmolarity of the glomerular filtrate and thereby hindering
tubular reabsorption of water. Excretion of chloride and sodium
is also enhanced
Mannitol
Indication and dose of the drug:
Cerebral
oedema: by
IV infusion, as
1.5-2g/kg
infused over
30-60minutes
Raised
intracranial or
intraocular
pressure: by
IV infusion as
1.5-2g/kg
infused over
30-60minutes
Mannitol
Drug interaction
Tobramycin Lurasidone
Nitroglycer
in
Trobramyci
n inhaled
Mannitol
Contra-indication
Pulmonary
oedema
Renal
failure
Severe
dehydratio
n
Severe
congestive
heart
failure
Mannitol
Adverse effect
Acute renal
failure(Larg
e doses)
chest pain
Fever
Circulatory
overload
Chills
Fluid and
electrolyte
imbalance
Magnesium Sulfate
Indications and Dosage
1 to 4 g magnesium sulfate (magnesium sulfate (magnesium sulfate
injection) injection) may be given intravenously in 10% to 20% solution
Convulsions (treatment) - Intravenous magnesium sulfate (magnesium
sulfate (magnesium sulfate injection) injection) is indicated for immediate
control of life-threatening convulsions in the treatment of severe toxemias
(pre-eclampsia and eclampsia) of pregnancy
Magnesium Sulfate
Mechanism Of Action
It produces
anticonvulsant effect
by decreasing the
amount of
acetylcholine
released at end plate
by motor nerve
impulse
Promotes movement
of calcium,potassium
and sodium in and
out and stabilizes
excitable
membranees
Magnesium Sulfate
Interactions
Doxycyclin
e
Tetracyclin
e
Minocyclin
e
Ciprofloxac
in
Magnesium Sulfate
Contraindication
Hypermag
nesemia
Pregnancy
Category:
D
Hypercalce
mia
Hypersensi
tivity
Myocardial
damage
Heart
block
Magnesium Sulfate
Adverse Effects
Flushing Drowsiness
Depressed
cardiac
function
Circulatory
Collapse
Respirator
y paralysis
Hypotensi
on
HEPARIN
Indications And Dosage
Deep Vein Thrombosis ,thrombosis, emboli, unstable angina
Treatment of deep-vein thrombosis and pulmonary embolism ; by
injection Adult loading dose of 500units [in severe pulmonary embolism
1000 unit
Prophylaxis in general surgery ,by SC injection Adult 2000units before
surgery and then every 8- 12hrs for 7 days.
HEPARIN Mechanism Of Action
Prevents blood clotting by its antithrombin activity. It directly suppresses
the activity of thrombin
Combines with antithrombin III (a protease inhibitor present in circulation)
and removes thrombin from circulation
Inactivates the active form of other clotting factors like IX, X, XI and XII
HEPARIN
Interactions
Argatroban
Bivalirudin
Dabigatran
Desirudin
HEPARIN Contraindication
Haemophilia
Severe
hypertension
Peptic ulcer
Cerebral
haemorrhage
Thrombocytope
nia
Renal & liver
disease
HEPARIN
Adverse Effects
Heparin Induced
Thrombocytopenia
Hematoma
Hemorrhage
Immune hypersensitivity
reaction
Erythema
Epinephrine
Mechanism of action
It acts by stimulating the à and ß-receptors of the adrenergic neurons
of sympathetic nervous system
Its alpha-adrenergic effects is much stronger than the beta-adrenergic
effects
Adrenoceptors Actions
à1-receptors Vasoconstriction, increased BP
, Mydriasis
à2-receptors Inhibits the release of noradrenaline, acetylcholine and
insulin
ß1-receptors Tachycardia, increase lipolysis, myocardial contractility and
renin
Epinephrine
Indication and dose of the drug
Cardiac Arrest: 1mg IV of 1:10000 solution every 3-5 minutes or iv
bolus(10ml)
Anaphylaxis (type 1): iv bolus, 0.5-1.0ml, may be repeated when
necessary
Refractory bradycardia and hypotension: 2- 10mcg/min
Asthma: 0.1-0.3mg SC or IM of 1:10,000 solution
Epinephrine Drug Interactions
Tranylcypromine
Amiodarone
Chlorpromazine Phenelzine
Amitriptyline
Quinidine
Epinephrine
Contraindications
Narrow angle glaucoma
Shock (other than anaphylactic
shock)
Coronary insufficiency
Pregnant and breast feeding
mothers
Labor (may delay second
stage)
Individuals with organic brain
damage
Epinephrine
Adverse effects of the drug
CNS: anxiety, fear, tension, headache, and tremor
Hemorrhage: The drug may induce cerebral hemorrhage as a result of a marked
elevation of blood pressure
Pulmonary edema
sweating, nausea and vomiting, pale skin, feeling short of breath, dizziness etc
Hydrocortisone
Adverse effects of the drug
It reduces the inflammatory reaction by limiting the capillary dilatation and
permeability of the vascular structures
It also restrict the accumulation of polymorphonuclear leukocytes and
macrophages and reduce the release of vasoactive kinins.
It also inhibit the release of destructive enzymes that attack the injury debris and
destroy normal tissue indiscriminately.
Hydrocortisone
Indication and dose of the drug
Acute adrenocortical insufficiency
Congenital Adrenal hyperplasia
The initial dose of hydrocortisone is 100 mg to 500 mg, depending on the
severity of the condition. This dose may be repeated at intervals of 2, 4 or 6
hours as indicated by the patient’s response and clinical condition.
Hydrocortisone
Drug interactions
Drugs such as phenobarbital, phenytoin and rifampin induces hepatic enzymes
and increases the clearance of hydrocortisone
Drugs such as troleandomycin and ketoconazole may inhibit the metabolism of
hydrocortisone and thus decrease their clearance
When used with high dose aspirin, clearance of asprin increases.
Hydrocortisone
Contraindications
Premature infants
Systemic fungal infections
Hypersensitivity
Hydrocortisone
Adverse effects of the drug
Sodium retention
Congestive heart failure in
susceptible patients
Hypertension
Abdominal distention
Loss of muscle mass
Convulsions
Potassium loss
Hypokalemic alkalosis
Headache
Diazepam
Mechanism of action
It acts by binding to GABA –A receptors (post synaptic
receptors) and increases it’s frequency of opening, leading to
potentiate the GABA effects
This opening leads to a increased conductance to chloride
ions, which produces membrane hyperpolarization, this
induces a neuronal inhibition which results in its sedative
action
Diazepam Indication and dose of the drug
SEIZURE DISORDERS: 0.2mg/kg repeat after 4- 12 hrs
MUSCLE SPASMS:5-10mg IV/IM initially
STATUS EPILEPTICUS: 5-10mg IV/IM not to exceed 30mg
Sedation—Midazolam is indicated for the sedation of patients in
intensive care settings, including intubated patients receiving
mechanical ventilation
Anesthesia, general, adjunct
Diazepam
Drug interactions
Drug interactions
Clamithromycin
Cimetidine
Carbamezipine
Rifampin
Drug interactions
Carbamezipine
Diazepam
Contraindications
Hypersensitivity Acute alcohol intoxication
Children < 6 months Breastfeeding
Sleep Apnea Severe Respiratory Depression
Diazepam
Adverse effects of the drug
Headache Dysarthria
Blurred vision
Fatigue
Respiratory
depression
Hypotension
BY
JINCE THOMAS
PROFESSOR
SJB COLLEGE OF
NURSING
BANGALORE-60
THANK YOU

More Related Content

What's hot

Etomidate a to z
Etomidate a to zEtomidate a to z
Etomidate a to z
dr tushar chokshi
 
Dopamine &amp; dobutamine
Dopamine &amp; dobutamineDopamine &amp; dobutamine
Dopamine &amp; dobutamine
DrVishal Kandhway
 
Amiodarone
AmiodaroneAmiodarone
Amiodarone
renjith2015
 
Adrenaline pharmacology
Adrenaline pharmacologyAdrenaline pharmacology
Adrenaline pharmacology
PARUL UNIVERSITY
 
Frusemide
FrusemideFrusemide
Midazolam in er 1
Midazolam in er 1Midazolam in er 1
Midazolam in er 1
MEEQAT HOSPITAL
 
Aminophylline drug
Aminophylline drugAminophylline drug
Aminophylline drug
sonalikoiri1
 
Heparin
HeparinHeparin
Ketamine
KetamineKetamine
Ketamine
Karunesh Kumar
 
Noradrenaline
NoradrenalineNoradrenaline
Noradrenalinebchnepal
 
Antiemetic's _ Ondansetron
Antiemetic's  _ OndansetronAntiemetic's  _ Ondansetron
Antiemetic's _ Ondansetron
Mr.Harshad Khade
 
Antiplatelet drugs (antithrombotics)
Antiplatelet drugs (antithrombotics)Antiplatelet drugs (antithrombotics)
Antiplatelet drugs (antithrombotics)
http://neigrihms.gov.in/
 
Atracurium Vecuronium Pancuronium
Atracurium Vecuronium PancuroniumAtracurium Vecuronium Pancuronium
Atracurium Vecuronium Pancuronium
Ranjith Thampi
 
Thiopentone and propofol
Thiopentone and propofolThiopentone and propofol
Thiopentone and propofol
razishahid
 
Insulin
InsulinInsulin
Insulin
Johny Wilbert
 
Vecuronium
VecuroniumVecuronium
Digoxin
DigoxinDigoxin

What's hot (20)

Etomidate a to z
Etomidate a to zEtomidate a to z
Etomidate a to z
 
Dopamine &amp; dobutamine
Dopamine &amp; dobutamineDopamine &amp; dobutamine
Dopamine &amp; dobutamine
 
Amiodarone
AmiodaroneAmiodarone
Amiodarone
 
Inotropic agents
Inotropic agentsInotropic agents
Inotropic agents
 
Adrenaline pharmacology
Adrenaline pharmacologyAdrenaline pharmacology
Adrenaline pharmacology
 
Amiodarone
AmiodaroneAmiodarone
Amiodarone
 
Frusemide
FrusemideFrusemide
Frusemide
 
Midazolam in er 1
Midazolam in er 1Midazolam in er 1
Midazolam in er 1
 
Emergency medicines
Emergency medicinesEmergency medicines
Emergency medicines
 
Aminophylline drug
Aminophylline drugAminophylline drug
Aminophylline drug
 
Heparin
HeparinHeparin
Heparin
 
Ketamine
KetamineKetamine
Ketamine
 
Noradrenaline
NoradrenalineNoradrenaline
Noradrenaline
 
Antiemetic's _ Ondansetron
Antiemetic's  _ OndansetronAntiemetic's  _ Ondansetron
Antiemetic's _ Ondansetron
 
Antiplatelet drugs (antithrombotics)
Antiplatelet drugs (antithrombotics)Antiplatelet drugs (antithrombotics)
Antiplatelet drugs (antithrombotics)
 
Atracurium Vecuronium Pancuronium
Atracurium Vecuronium PancuroniumAtracurium Vecuronium Pancuronium
Atracurium Vecuronium Pancuronium
 
Thiopentone and propofol
Thiopentone and propofolThiopentone and propofol
Thiopentone and propofol
 
Insulin
InsulinInsulin
Insulin
 
Vecuronium
VecuroniumVecuronium
Vecuronium
 
Digoxin
DigoxinDigoxin
Digoxin
 

Similar to Emergency drugs

Common emergency drugs in medicine
Common emergency drugs in medicineCommon emergency drugs in medicine
Common emergency drugs in medicine
Oluwatobi Olusiyan
 
Emergency drugs in nephrology ward
Emergency drugs in nephrology wardEmergency drugs in nephrology ward
Emergency drugs in nephrology wardSamrat Joshi
 
Autonomic nervous system pharmacology
Autonomic nervous system pharmacologyAutonomic nervous system pharmacology
Autonomic nervous system pharmacology
bigboss716
 
Anti-Hypertensive drugs
Anti-Hypertensive drugsAnti-Hypertensive drugs
Anti-Hypertensive drugs
SrinivasSree11
 
contrast_radiology.ppt
contrast_radiology.pptcontrast_radiology.ppt
contrast_radiology.ppt
abelllll
 
Anticholinergic drugs
Anticholinergic drugsAnticholinergic drugs
Anticholinergic drugs
Dr Pralhad Patki
 
A Practical Approach to Ionotropes and vasopressors
A Practical Approach to Ionotropes and vasopressors A Practical Approach to Ionotropes and vasopressors
A Practical Approach to Ionotropes and vasopressors
Aneesh Bhandary
 
48078289 pharmacology-review-for-nurses
48078289 pharmacology-review-for-nurses48078289 pharmacology-review-for-nurses
48078289 pharmacology-review-for-nursesThania Boquiren
 
Cardiovascular Drugs
Cardiovascular Drugs Cardiovascular Drugs
Cardiovascular Drugs
Rajee Ravindran
 
Anti arrythmic drugs.pptx
Anti arrythmic drugs.pptxAnti arrythmic drugs.pptx
Anti arrythmic drugs.pptx
AllsunSweetlineMS
 
Anticholinergic part 1, Dr. Kiran Piparva, AIIMS,Rajkot
Anticholinergic part 1, Dr. Kiran Piparva, AIIMS,RajkotAnticholinergic part 1, Dr. Kiran Piparva, AIIMS,Rajkot
Anticholinergic part 1, Dr. Kiran Piparva, AIIMS,Rajkot
KiranPiparva
 
Cholinergic antagonists
Cholinergic antagonistsCholinergic antagonists
Cholinergic antagonistscoolboy101pk
 
16 Pharmacology.ppt
16 Pharmacology.ppt16 Pharmacology.ppt
16 Pharmacology.pptShama
 
Drug Interactions ppt.ppt
Drug Interactions ppt.pptDrug Interactions ppt.ppt
Drug Interactions ppt.ppt
Haramaya University
 
neweranticoagulants-160612164446.pdf
neweranticoagulants-160612164446.pdfneweranticoagulants-160612164446.pdf
neweranticoagulants-160612164446.pdf
ToqeerHussain22
 
Pharmacology Hematologic Drugs
Pharmacology   Hematologic DrugsPharmacology   Hematologic Drugs
Pharmacology Hematologic Drugs
jben501
 
Anticoagulants
 Anticoagulants Anticoagulants
Anticoagulants
Dr VARUN RAGHAVAN
 
Archer NCLEX Pharmacology crash course - Webinar
Archer NCLEX Pharmacology crash course - WebinarArcher NCLEX Pharmacology crash course - Webinar
Archer NCLEX Pharmacology crash course - Webinar
Archer Review USMLE and NCLEX
 

Similar to Emergency drugs (20)

Common emergency drugs in medicine
Common emergency drugs in medicineCommon emergency drugs in medicine
Common emergency drugs in medicine
 
Emergency drugs in nephrology ward
Emergency drugs in nephrology wardEmergency drugs in nephrology ward
Emergency drugs in nephrology ward
 
Autonomic nervous system pharmacology
Autonomic nervous system pharmacologyAutonomic nervous system pharmacology
Autonomic nervous system pharmacology
 
Anti-Hypertensive drugs
Anti-Hypertensive drugsAnti-Hypertensive drugs
Anti-Hypertensive drugs
 
contrast_radiology.ppt
contrast_radiology.pptcontrast_radiology.ppt
contrast_radiology.ppt
 
Antiemetics
AntiemeticsAntiemetics
Antiemetics
 
Anticholinergic drugs
Anticholinergic drugsAnticholinergic drugs
Anticholinergic drugs
 
A Practical Approach to Ionotropes and vasopressors
A Practical Approach to Ionotropes and vasopressors A Practical Approach to Ionotropes and vasopressors
A Practical Approach to Ionotropes and vasopressors
 
48078289 pharmacology-review-for-nurses
48078289 pharmacology-review-for-nurses48078289 pharmacology-review-for-nurses
48078289 pharmacology-review-for-nurses
 
Cardiovascular Drugs
Cardiovascular Drugs Cardiovascular Drugs
Cardiovascular Drugs
 
Anti arrythmic drugs.pptx
Anti arrythmic drugs.pptxAnti arrythmic drugs.pptx
Anti arrythmic drugs.pptx
 
Anticholinergic part 1, Dr. Kiran Piparva, AIIMS,Rajkot
Anticholinergic part 1, Dr. Kiran Piparva, AIIMS,RajkotAnticholinergic part 1, Dr. Kiran Piparva, AIIMS,Rajkot
Anticholinergic part 1, Dr. Kiran Piparva, AIIMS,Rajkot
 
Cholinergic antagonists
Cholinergic antagonistsCholinergic antagonists
Cholinergic antagonists
 
16 Pharmacology.ppt
16 Pharmacology.ppt16 Pharmacology.ppt
16 Pharmacology.ppt
 
Pharmacotherapy of vertigo
Pharmacotherapy of vertigoPharmacotherapy of vertigo
Pharmacotherapy of vertigo
 
Drug Interactions ppt.ppt
Drug Interactions ppt.pptDrug Interactions ppt.ppt
Drug Interactions ppt.ppt
 
neweranticoagulants-160612164446.pdf
neweranticoagulants-160612164446.pdfneweranticoagulants-160612164446.pdf
neweranticoagulants-160612164446.pdf
 
Pharmacology Hematologic Drugs
Pharmacology   Hematologic DrugsPharmacology   Hematologic Drugs
Pharmacology Hematologic Drugs
 
Anticoagulants
 Anticoagulants Anticoagulants
Anticoagulants
 
Archer NCLEX Pharmacology crash course - Webinar
Archer NCLEX Pharmacology crash course - WebinarArcher NCLEX Pharmacology crash course - Webinar
Archer NCLEX Pharmacology crash course - Webinar
 

Recently uploaded

Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
Peter Windle
 
Digital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion DesignsDigital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion Designs
chanes7
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
Atul Kumar Singh
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
TechSoup
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
heathfieldcps1
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
Jean Carlos Nunes Paixão
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
Levi Shapiro
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
DhatriParmar
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
Jisc
 
S1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptxS1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptx
tarandeep35
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
Vikramjit Singh
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBCSTRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
kimdan468
 

Recently uploaded (20)

Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
 
Digital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion DesignsDigital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion Designs
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
 
S1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptxS1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptx
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBCSTRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
 

Emergency drugs